Dr. Matthew Christopher Tate, MD, PhD

  • Chicago, IL
  • Neurosurgeon
NPI1730217563PAC ID8628203858
Medicare services, 2024
350
Medicare patients, 2024
228
Part D claims, 2024
18
Publications
82
Clinical trials
1
Practice address
675 N Saint Clair St Ste 19-100 Suite 19-100, Chicago, IL 60611
Practice phone
Call (312) 664-3278
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Northwestern Medical Group

Multi-specialty group site · Chicago, Illinois

See all 6 affiliations

Find Dr. Tate's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Matthew Christopher Tate is a neurosurgeon in Chicago, Illinois

Dr. Tate practices at Northwestern Medical Group in Chicago, Illinois.

Dr. Tate's NPI, 1730217563, was assigned on March 1, 2007. Dr. Tate graduated from Emory University School of Medicine in 2006. Dr. Tate holds Illinois license 036133276.

NPI and contact details
Medicare PAC ID
8628203858
NPI enumeration date
March 1, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(312) 664-3278
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
46
Medical school graduation
2006

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Matthew Christopher Tate practices at Northwestern Medical Group in Chicago, Illinois

Dr. Tate's primary practice is Northwestern Medical Group, at 675 N Saint Clair St Ste 19-100 Suite 19-100, Chicago, IL 60611. The practice phone is (312) 664-3278.

  • Northwestern Medical Group
    675 N Saint Clair St Ste 19-100 Suite 19-100, Chicago, IL 60611Phone(312) 664-3278

Source: Dmand AI Affiliation Data

Dr. Matthew Christopher Tate is affiliated with 5 sites of care and 1 medical group

Dr. Tate's primary practice is Northwestern Medical Group in Chicago, Illinois. Dr. Tate is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Tate to 3 more hospitals, each named with a free account.

See all 6 affiliations for Dr. Tate

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Matthew Christopher Tate's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tate practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Northwestern Medical GroupAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Tate practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Matthew Christopher Tate is one of 303 neurosurgeons in Illinois

Neurological surgery is Dr. Tate's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Tate is licensed in Illinois.

Specialties and state licenses

  • Neurological surgery, IllinoisPrimaryLicense 036133276 · taxonomy 207T00000X

Neurosurgeons near Dr. Tate

Counts of neurosurgeons with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Matthew Christopher Tate billed Medicare for 350 services in 2024

CMS data shows 350 Medicare services from Dr. Tate across 13 procedure codes in 2024, for 228 Medicare patients. Medicare paid $88,739 for them.

Medicare services, 2024350
Medicare patients228
Paid by Medicare$88,739
Procedure codes13

Dr. Tate's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2772024: 2654%
Surgery
2023: 602024: 8542%

Where Dr. Tate's Medicare services took place, 2024

  • In an office23266%
  • In a facility11834%

Dr. Tate compared with the Illinois median for neurosurgeons, 2024

  • Dr. Tate
  • Illinois median
Medicare services
350vs 18490% above
Medicare patients
228vs 14261% above
Part D claims
12vs 3263% below

Medians across 252 neurosurgeons in Illinois with Dmand AI profiles that report each measure.

Dr. Tate's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Tate

Need commercial claims for Dr. Tate?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Tate and other neurosurgeons in Illinois.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Matthew Christopher Tate treated 228 Medicare patients in 2024, average age 73

CMS counts 228 Medicare patients who saw Dr. Tate in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tate's median patient age at 71, with 59% women.

Medicare patients, 2024228
Average age73
Average risk score1.56
Also on Medicaid12%

Dr. Tate's Medicare patients by age, 2024

Dr. Tate's Medicare patients by sex, 2024

  • Women12555%
  • Men10345%

Chronic conditions among Dr. Tate's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis46%
  4. Mood disorders36%
  5. Anxiety32%
  6. Ischemic heart disease32%
  7. Cancer31%
  8. Depression31%

Share of Medicare patients with each condition. A patient can have several.

Dr. Tate's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women59%
  • Men41%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Matthew Christopher Tate wrote 18 Medicare Part D claims in 2024

In 2024, Dr. Tate wrote 18 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $529 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

Part D claims, 202418
Drugs named by CMS1
Total drug cost$529

Dr. Tate's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 222024: 1245%

Drugs named by CMS: 1 in 2024, 1 in 2023.

See all prescribing by Dr. Tate

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Matthew Christopher Tate scored 95 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Tate for performance year 2024, reported through an alternative payment model (APM). Dr. Tate accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tate as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Tate's MIPS scores, performance year 2024

  • 95of 100Final score
  • 83of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find neurosurgeons like Dr. Tate by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Matthew Christopher Tate has 82 publications on record

Dmand AI links 82 papers to Dr. Tate, published from 2010 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Brain Neoplasms, Brain Mapping and Seizures. Dr. Tate has published most often in World Neurosurg. Dr. Tate's most frequent co-authors are Jessica W. Templer, MD, Sean Sachdev and Joshua M. Rosenow, MD.

Papers82
Years published2010 to 2025

Dr. Tate's papers by year, 2016 to 2025

Topics Dr. Tate writes about most

  • Brain Neoplasms
  • Brain Mapping
  • Seizures
  • Craniotomy
  • Electrocorticography
  • Glioma
  • Brain
  • Neurosurgical Procedures

Dr. Tate's most frequent co-authors

Recent publications by Dr. Tate

See all 82 publications and co-authors

See who Dr. Tate researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Tate works with, so you can find a warm path to the right neurosurgeons.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Matthew Christopher Tate has worked on 1 clinical trial

Dmand AI links Dr. Tate to 1 clinical trial. Conditions studied include Glioblastoma and Astrocytoma.

Conditions in Dr. Tate's trials

  • Glioblastoma
  • Astrocytoma

Investigators on the most trials with Dr. Tate

Recent clinical trials with Dr. Tate

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Matthew Christopher Tate received $24,406 in industry payments from 2019 to 2025

CMS Open Payments shows 16 general payments to Dr. Tate from 7 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 93% of the total. Boston Scientific Corporation paid the most, $21,156.

General payments to Dr. Tate by program year, 2019 to 2025

General payments to Dr. Tate by kind, 2019 to 2025

$24.4Kin total
  • Consulting fees$22,80093%
  • Food and beverage$1,6067%

Companies that paid Dr. Tate the most, 2019 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Tate

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Matthew Christopher Tate graduated from Emory University School of Medicine

Dr. Tate graduated from Emory University School of Medicine in 2006.

  1. Medical schoolEmory University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Matthew Christopher Tate's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Matthew Christopher Tate

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Matthew Christopher Tate's NPI number?

Dr. Matthew Christopher Tate's NPI number is 1730217563. It was assigned on March 1, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Matthew Christopher Tate?

Dr. Matthew Christopher Tate is a neurosurgeon in Chicago, Illinois. The primary specialty in the NPI Registry is Neurological Surgery Physician (taxonomy code 207T00000X).

Where does Dr. Matthew Christopher Tate practice?

Dr. Tate practices at 675 N Saint Clair St Ste 19-100 Suite 19-100, Chicago, IL 60611. Dr. Tate's primary practice is Northwestern Medical Group in Chicago, Illinois. Dmand AI also links Dr. Tate to 3 hospitals.

What is Dr. Matthew Christopher Tate's office phone number?

The practice phone on file for Dr. Tate is (312) 664-3278.

What is Dr. Matthew Christopher Tate's medical license number?

Dr. Tate holds Illinois license 036133276.

Which hospitals is Dr. Matthew Christopher Tate affiliated with?

Dr. Tate is affiliated with Northwestern Memorial Hospital. Dmand AI links Dr. Tate to 3 more hospitals.

What medical group is Dr. Matthew Christopher Tate part of?

Dr. Tate is linked to Northwestern Medical Faculty Foundation.

Does Dr. Matthew Christopher Tate accept Medicare?

Yes. CMS data shows Dr. Tate billed Medicare for 350 services in 2024, and Dr. Tate accepts Medicare assignment.

Does Dr. Matthew Christopher Tate offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Tate as offering telehealth services.

What is Dr. Matthew Christopher Tate's MIPS score?

Dr. Tate's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Matthew Christopher Tate see?

CMS counts 228 Medicare patients who saw Dr. Tate in 2024, with an average age of 73.

What services does Dr. Matthew Christopher Tate bill to Medicare?

In 2024, Dr. Tate's most billed Medicare services were office visit, established patient (99213), surgery: brain, spine and nerves (61781) and office visit, established patient (99214).

Where did Dr. Matthew Christopher Tate go to medical school?

Dr. Tate graduated from Emory University School of Medicine in 2006.

What drugs does Dr. Matthew Christopher Tate prescribe most?

In 2024 Medicare Part D data, Dr. Tate's most prescribed drugs by claims were Levetiracetam.

Has Dr. Matthew Christopher Tate received payments from drug or device companies?

CMS Open Payments shows $24,406 in general payments to Dr. Tate from 7 companies from 2019 to 2025. The largest total came from Boston Scientific Corporation.

How long has Dr. Matthew Christopher Tate been practicing?

Dr. Tate graduated from medical school in 2006, 20 years ago.

Does Dr. Matthew Christopher Tate do research?

Dmand AI links 82 publications to Dr. Tate, published from 2010 to 2025. Dr. Tate has worked on 1 clinical trial.

Who does Dr. Matthew Christopher Tate publish with?

Dr. Tate's most frequent co-authors are Jessica W. Templer, MD (16 shared papers), Sean Sachdev (13 shared papers) and Joshua M. Rosenow, MD (12 shared papers).

Selling to neurological surgery practices?

See neurosurgeons in Illinois by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)